Disruption of the PKA-PIMT-Ep300 axis (which is achieved by PIMT depletion) also suppressed gluconeogenesis, suggesting that this module is a promising pharmacological target for treating obesity and type 2 diabetes. This evidence concerns the gene EP300 and obesity due to melanocortin 4 receptor deficiency.